Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release

Journal of Neuroscience

Volumn 35, Issue 27, 2015, Pages 10039-10057

  Lee, Sang Hun ^a   Ledri, Marco ^b   Tóth, Blanka ^c   Marchionni, Ivan ^a   Henstridge, Christopher M ^b   Dudok, Barna ^b,d   Kenesei, Kata ^b   Barna, László ^b   Szabó, Szilárd I ^b   Renkecz, Tibor ^c   Oberoi, Michelle ^a   Watanabe, Masahiko ^e   Limoli, Charles L ^g   Horvai, George ^c,f   Soltesz, Ivan ^a   Katona, István ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e HOKKAIDO UNIVERSITY   (Japan)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2 arachidonoylglycerol; Endocannabinod; GABA; Hippocampus; Interneuron; TRPV1

Indexed keywords

1 (2, 4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 4 [BIS (1, 3 BENZODIOXOL 5 YL) HYDROXYMETHYL] 1 PIPERIDINECARBOXYLIC ACID 4 NITROPHENYL ESTER; ACYLGLYCEROL LIPASE; ANANDAMIDE; ENDOCANNABINOID; ENDOVANILLOID; FATTY ACID AMIDASE; N PYRIDIN 3 YL 4 [[3 [5 (TRIFLUOROMETHYL)PYRIDIN 2 YL]OXYPHENYL]METHYL]PIPERIDINE 1 CARBOXAMIDE); PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; [8 CHLORO1 (2,4 DICHLOROPHENYL) N PIPERIDIN 1 YL 5,6 DIHYDRO 4H BENZO[2,3]CYCLOHEPTA[2,4B]PYRAZOLE 3 CARBOXAMINE]; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2-ARACHIDONYLGLYCEROL; 4 AMINOBUTYRIC ACID; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; ENZYME INHIBITOR; PF 3845; PIPERIDINE DERIVATIVE; PYRIDINE DERIVATIVE; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

4 AMINOBUTYRIC ACID RELEASE; ADULT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOGOLD STAINING; IMMUNOHISTOCHEMISTRY; INTERNEURON; LIQUID CHROMATOGRAPHY; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TANDEM MASS SPECTROMETRY; WHOLE CELL PATCH CLAMP; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; INHIBITORY POSTSYNAPTIC POTENTIAL; METABOLISM; NERVE CELL; PHYSIOLOGY; SYNAPSE; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOID RECEPTOR MODULATORS; ENDOCANNABINOIDS; ENZYME INHIBITORS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLYCERIDES; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PIPERIDINES; PYRAZOLES; PYRIDINES; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SYNAPSES; TRPV CATION CHANNELS;

EID: 84936883088     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4112-14.2015     Document Type: Article

References (114)

1. Ahn K, Johnson DS, Mileni M, Beidler D, Long JZ, McKinney MK, Weerapana E, Sadagopan N, Liimatta M, Smith SE, Lazerwith S, Stiff C, Kamtekar S, Bhattacharya K, Zhang Y, Swaney S, Van Becelaere K, Stevens RC, Cravatt BF (2009) Discovery and caharacterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol 16: 411-420. CrossRef Medline.
2. Alger BE (2012) Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. J Physiol 590: 2203-2212. CrossRef Medline.
3. Ali AB, Todorova M (2010) Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. Eur J Neurosci 31: 1196-1207. CrossRef Medline.
4. Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, Zieglgänsberger W, Rammes G (2004) Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 24: 9953-9961. CrossRef Medline.
5. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163: 463-468. CrossRef Medline.
6. Blankman JL, Cravatt BF (2013) Chemical probes of endocannabinoid metabolism. Pharmacol Rev 65: 849-871. CrossRef Medline.
7. Blankman JL, Simon GM, Cravatt BF (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14: 1347-1356. CrossRef Medline.
8. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272: 22330-22339. CrossRef Medline.
9. Branco T, Staras K (2009) The probability of neurotransmitter release: variability and feedback control at single synapses. Nat Rev Neurosci 10: 373-383. CrossRef Medline.
10. Brickley SG, Mody I (2012) Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron 73: 23-34. CrossRef Medline.
11. Cachope R (2012) Functional diversity on synaptic plasticity mediated by endocannabinoids. Philos Trans R Soc Lond B Biol Sci 367: 3242-3253. CrossRef Medline.
12. Castillo PE, Younts TJ, Chávez AE, Hashimotodani Y (2012) Endocannabinoid signaling and synaptic function. Neuron 76: 70-81. CrossRef Medline.
13. Chávez AE, Chiu CQ, Castillo PE (2010) TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat Neurosci 13: 1511-1518. CrossRef Medline.
14. Chávez AE, Hernández VM, Rodenas-Ruano A, Chan CS, Castillo PE (2014) Compartment-specific modulation of GABAergic synaptic transmission by TRPV1 channels in the dentate gyrus. J Neurosci 34: 16621-16629. CrossRef Medline.
15. Chen K, Ratzliff A, Hilgenberg L, Gulyás A, Freund TF, Smith M, Dinh TP, Piomelli D, Mackie K, Soltesz I (2003) Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39: 599-611. CrossRef Medline.
16. Chen K, Neu A, Howard AL, Földy C, Echegoyen J, Hilgenberg L, Smith M, Mackie K, Soltesz I (2007) Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J Neurosci 27: 46-58. CrossRef Medline.
17. Cope DW, Maccaferri G, Márton LF, Roberts JD, Cobden PM, Somogyi P (2002) Cholecystokinin-immunopositive basket and Schaffer collateralassociated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience 109: 63-80. CrossRef Medline.
18. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87. CrossRef Medline.
19. Cristino L, Starowicz K, De Petrocellis L, Morishita J, Ueda N, Guglielmotti V, Di Marzo V (2008) Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. Neuroscience 151: 955-968. CrossRef Medline.
20. Dani A, Huang B, Bergan J, Dulac C, Zhuang X (2010) Superresolution imaging of chemical synapses in the brain. Neuron 68: 843-856. CrossRef Medline.
21. D'Antona AM, Ahn KH, Kendall DA (2006) Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization. Biochemistry 45: 5606-5617. CrossRef Medline.
22. Dias RB, Rombo DM, Ribeiro JA, Henley JM, Sebastião AM (2013) Adenosine: setting the stage for plasticity. Trends Neurosci 36: 248-257. CrossRef Medline.
23. Di Marzo V, De Petrocellis L (2012) Why do cannabinoid receptors have more than one endogenous ligand? Philos Trans R Soc Lond B Biol Sci 367: 3216-3228. CrossRef Medline.
24. Dincheva I, Drysdale AT, Hartley CA, Johnson DC, Jing D, King EC, Ra S, Gray JM, Yang R, DeGruccio AM, Huang C, Cravatt BF, Glatt CE, Hill MN, Casey BJ, Lee FS (2015) FAAH genetic variation enhances frontoamygdala function in mouse and human. Nat Commun 6: 6395. CrossRef Medline.
25. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, PiomelliD (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99: 10819-10824. CrossRef Medline.
26. Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, Watanabe M, Sagheddu C, Melis M, Pistis M, Soltesz I, Katona I (2015) Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat Neurosci 18: 75-86. CrossRef Medline.
27. Dvorzhak A, Semtner M, Faber DS, Grantyn R (2013) Tonic mGluR5/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin. J Physiol 591: 1145-1166. CrossRef Medline.
28. Egertová M, Giang DK, Cravatt BF, Elphick MR (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc Biol Sci 265: 2081-2085. CrossRef Medline.
29. Földy C, Neu A, Jones MV, Soltesz I (2006) Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition ofGABA release. J Neurosci 26: 1465-1469. CrossRef Medline.
30. Földy C, Malenka RC, Südhof TC (2013) Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 78: 498-509. CrossRef Medline.
31. Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T, Kano M (2004) Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci 19: 2682-2692. CrossRef Medline.
32. Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, Doherty EM, Norman MH, Wild KD, Bannon AW, Louis JC, Treanor JJ (2005) AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2, 3-dihydrobenzo[b][1, 4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313: 474-484. CrossRef Medline.
33. Grueter BA, Brasnjo G, Malenka RC (2010) Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat Neurosci 13: 1519-1525. CrossRef Medline.
34. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF (2004) Segregation of two endocannabinoid-hydrolyzing enzymes into pre-and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20: 441-458. CrossRef Medline.
35. Gunduz-Cinar O, HillMN, McEwen BS, HolmesA (2013) AmygdalaFAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci 34: 637-644. CrossRef Medline.
36. Gyombolai P, Tó th AD, Tímár D, Turu G, Hunyady L (2015) Mutations in the "DRY" motif of the CB1 cannabinoid receptor result in biased receptor variants. J Mol Endocrinol 54: 75-89. CrossRef Medline.
37. Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Wit H, Hillard CJ, Van Cauter E (2015) Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. J Clin Endocrinol Metab 100: 220-226. CrossRef Medline.
38. Hashimotodani Y, Ohno-Shosaku T, Kano M (2007) Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci 27: 1211-1219. CrossRef Medline.
39. Hentges ST, Low MJ, Williams JT (2005) Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci 25: 9746-9751. CrossRef Medline.
40. Hillard CJ (2000) Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Mediat 61: 3-18. CrossRef Medline.
41. Hoffman AF, Lupica CR (2000) Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 20: 2470-2479. Medline.
42. Horváth E, Woodhams SG, Nyilas R, Henstridge CM, Kano M, Sakimura K, Watanabe M, Katona I (2014) Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. Eur J Neurosci 39: 419-434. CrossRef Medline.
43. Huang GZ, Woolley CS (2012) Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluRdependent mechanism. Neuron 74: 801-808. CrossRef Medline.
44. Iremonger KJ, Wamsteeker Cusulin JI, Bains JS (2013) Changing the tune: plasticity and adaptation of retrograde signals. Trends Neurosci 36: 471-479. CrossRef Medline.
45. Kallendrusch S, Hobusch C, Ehrlich A, Nowicki M, Ziebell S, Bechmann I, Geisslinger G, Koch M, Dehghani F (2012) Intrinsic up-regulation of 2-AG favors an area specific neuronal survival in different in vitro models of neuronal damage. PLoS One 7: e51208. CrossRef Medline.
46. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81. CrossRef Medline.
47. Katona I, Freund TF (2012) Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci 35: 529-558. CrossRef Medline.
48. Katona I, Sperlágh B, Sík A, Käfalvi A, Vizi ES, Mackie K, Freund TF (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544-4558. Medline.
49. Katona I, UrbánGM, WallaceM, Ledent C, JungKM, Piomelli D, Mackie K, Freund TF (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637. CrossRef Medline.
50. Kenakin T (2004) Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25: 186-192. CrossRef Medline.
51. Khlaifia A, Farah H, Gackiere F, Tell F (2013) Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-Hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers. J Neurosci 33: 12627-12637. CrossRef Medline.
52. Kim J, Alger BE (2010) Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 13: 592-600. CrossRef Medline.
53. Klausberger T, Somogyi P (2008) Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321: 53-57. CrossRef Medline.
54. Ladarre D, Roland AB, Biedzinski S, Ricobaraza A, Lenkei Z (2014) Polarized cellular patterns of endocannabinoid production and detection shape cannabinoid signaling in neurons. Front Cell Neurosci 8: 426. CrossRef Medline.
55. Lee SH, Földy C, Soltesz I (2010) Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J Neurosci 30: 7993-8000. CrossRef Medline.
56. Lee SH, Marchionni I, Bezaire M, Varga C, Danielson N, Lovett-Barron M, Losonczy A, Soltesz I (2014) Parvalbumin-positive basket cells differentiate among hippocampal pyramidal cells. Neuron 82: 1129-1144. CrossRef Medline.
57. Lenkey N, Kirizs T, Holderith N, Máté Z, Szabó G, Vizi ES, Hájos N, Nusser Z (2015) Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals. Nat Commun 6: 6557. CrossRef Medline.
58. Lerner TN, Kreitzer AC (2012) RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron 73: 347-359. CrossRef Medline.
59. Leterrier C, Lainé J, Darmon M, Boudin H, Rossier J, Lenkei Z (2006) Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J Neurosci 26: 3141-3153. CrossRef Medline.
60. Li HB, Mao RR, Zhang JC, Yang Y, Cao J, Xu L (2008) Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol Psychiatry 64: 286-292. CrossRef Medline.
61. Liedhegner ES, Sasman A, Hillard CJ (2014) Brain region-specific changes in N-acylethanolamine contents with time of day. J Neurochem 128: 491-506. CrossRef Medline.
62. Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF (2009a) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A 106: 20270-20275. CrossRef Medline.
63. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF (2009b) Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5: 37-44. CrossRef Medline.
64. Losonczy A, Biró AA, Nusser Z (2004) Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci U S A 101: 1362-1367. CrossRef Medline.
65. LovingerDM (2008) Presynaptic modulation by endocannabinoids. Handb Exp Pharmacol 184: 435-477. CrossRef Medline.
66. LudányiA, ErossL, CzirjakS, VajdaJ, HalászP, WatanabeM, PalkovitsM, Maglóczky Z, Freund TF, Katona I (2008) Downregulation of theCB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci 28: 2976-2990. CrossRef Medline.
67. Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, Gasperi V, Prosperetti C, Bernardi G, Finazzi-Agrò A, Cravatt BF, Centonze D (2008) Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11: 152-159. CrossRef Medline.
68. Marder E (2012) Neuromodulation of neuronal circuits: back to the future. Neuron 76: 1-11. CrossRef Medline.
69. Marsch R, Foeller E, Rammes G, Bunck M, Kössl M, Holsboer F, Zieglgänsberger W, Landgraf R, Lutz B, Wotjak CT (2007) Reduced anxiety, con-ditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci 27: 832-839. CrossRef Medline.
70. Mathur BN, Tanahira C, Tamamaki N, Lovinger DM (2013) Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity. Nat Neurosci 16: 1275-1283. CrossRef Medline.
71. Mato S, Pazos A, Valdizán EM (2002) Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain. Eur J Pharmacol 443: 43-46. CrossRef Medline.
72. Melis M, Greco B, Tonini R (2014) Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction. Eur J Neurosci 39: 1189-1201. CrossRef Medline.
73. Meye FJ, Trezza V, Vanderschuren LJ, Ramakers GM, AdanRA (2013) Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity. Mol Psychiatry 18: 1294-1301. CrossRef Medline.
74. Moreira FA, Aguiar DC, Terzian AL, Guimarães FS, Wotjak CT (2012) Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? Neuroscience 204: 186-192. CrossRef Medline.
75. Musella A, De Chiara V, Rossi S, Cavasinni F, Castelli M, Cantarella C, Mataluni G, Bernardi G, Centonze D (2010) Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Neuroscience 167: 864-871. CrossRef Medline.
76. Neu A, Földy C, Soltesz I (2007) Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol 578: 233-247. CrossRef Medline.
77. Niehaus JL, Liu Y, Wallis KT, Egertová M, Bhartur SG, Mukhopadhyay S, Shi S, He H, Selley DE, Howlett AC, Elphick MR, Lewis DL (2007) CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. Mol Pharmacol 72: 1557-1566. CrossRef Medline.
78. Nissen W, Szabo A, Somogyi J, Somogyi P, Lamsa KP (2010) Cell typespecific long-term plasticity at glutamatergic synapses onto hippocampal interneurons expressing either parvalbumin or CB1 cannabinoid receptor. J Neurosci 30: 1337-1347. CrossRef Medline.
79. Nyíri G, Cserép C, Szabadits E, Mackie K, Freund TF (2005) CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 136: 811-822. CrossRef Medline.
80. Ohno-Shosaku T, Kano M (2014) Endocannabinoid-mediated retrograde modulation of synaptic transmission. Curr Opin Neurobiol 29: 1-8. CrossRef Medline.
81. Oliet SH, Baimoukhametova DV, Piet R, Bains JS (2007) Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing. J Neurosci 27: 1325-1333. CrossRef Medline.
82. Pan B, Wang W, Zhong P, Blankman JL, Cravatt BF, Liu QS (2011) Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J Neurosci 31: 13420-13430. CrossRef Medline.
83. Pan X, Ikeda SR, Lewis DL (1998) SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 54: 1064-1072. Medline.
84. Pardini M, Krueger F, Koenigs M, Raymont V, Hodgkinson C, Zoubak S, Goldman D, Grafman J (2012) Fatty-acid amide hydrolase polymorphisms and post-traumatic stress disorder after penetrating brain injury. Transl Psychiatry 2: e75. CrossRef Medline.
85. Pawelzik H, Hughes DI, Thomson AM (2002) Physiological and morphological diversity of immunocytochemically defined parvalbumin-and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus. J Comp Neurol 443: 346-367. CrossRef Medline.
86. PertweeRG (2005) Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 76: 1307-1324. CrossRef Medline.
87. Piomelli D (2014) More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology 76: 228-234. CrossRef Medline.
88. Puente N, Cui Y, Lassalle O, Lafourcade M, Georges F, Venance L, Grandes P, Manzoni OJ (2011) Polymodal activation of the endocannabinoid system in the extended amygdala. Nat Neurosci 14: 1542-1547. CrossRef Medline.
89. Puente N, Reguero L, Elezgarai I, Canduela MJ, Mendizabal-Zubiaga J, Ramos-Uriarte A, Fernández-Espejo E, Grandes P (2015) The transient receptor potential vanilloid-1 is localized at excitatory synapses in the mouse dentate gyrus. Brain Struct Funct 220: 1187-1194. CrossRef Medline.
90. Roberto M, Cruz M, Bajo M, Siggins GR, Parsons LH, Schweitzer P (2010) The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology 35: 1962-1972. CrossRef Medline.
91. Ruiu S, Pinna GA, Marchese G, Mussinu JM, Saba P, Tambaro S, Casti P, Vargiu R, Pani L (2003) Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 306: 363-370. CrossRef Medline.
92. Rust MJ, Bates M, Zhuang X (2006) Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM). Nat Methods 3: 793-795. CrossRef Medline.
93. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, Thomas EA, Selley DE, Sim-Selley LJ, Liu QS, Lichtman AH, Cravatt BF (2010) Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13: 1113-1119. CrossRef Medline.
94. Serrano A, Rivera P, Pavon FJ, Decara J, Suárez J, Rodriguez de Fonseca F, Parsons LH (2012) Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala. Alcohol Clin Exp Res 36: 984-994. CrossRef Medline.
95. Simon AC, Loverdo C, Gaffuri AL, Urbanski M, Ladarre D, Carrel D, Rivals I, Leterrier C, Benichou O, Dournaud P, Szabo B, Voituriez R, Lenkei Z (2013) Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface. J Mol Cell Biol 5: 250-265. CrossRef Medline.
96. Smith TH, Blume LC, Straiker A, Cox JO, David BG, McVoy JR, Sayers KW, Poklis JL, Abdullah RA, Egertová M, Chen CK, Mackie K, Elphick MR, Howlett AC, Selley DE (2015) Cannabinoid receptorinteracting protein 1a modulates CB1 receptor signaling and regulation. Mol Pharmacol 87: 747-765. CrossRef Medline.
97. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778. CrossRef Medline.
98. Straiker A, Mackie K (2009) Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience 163: 190-201. CrossRef Medline.
99. Sullivan JM (1999) Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J Neurophysiol 82: 1286-1294. Medline.
100. Sumislawski JJ, Ramikie TS, Patel S (2011) Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stressinduced behavioral adaptation. Neuropsychopharmacology 36: 2750-2761. CrossRef Medline.
101. Szabó GG, Lenkey N, Holderith N, Andrási T, Nusser Z, Hájos N (2014a) Presynaptic calcium channel inhibition underlies CB1 cannabinoid receptor-mediated suppression of GABA release. J Neurosci 34: 7958-7963. CrossRef Medline.
102. Szabó GG, Papp OI, Má té Z, Szabó G, Há jos N (2014b) Anatomically heterogeneous populations of CB1 cannabinoid receptor-expressing interneurons in the CA3 region of the hippocampus show homogeneous input-output characteristics. Hippocampus 24: 1506-1523. CrossRef Medline.
103. Takács VT, Szõnyi A, Freund TF, Nyiri G, Gulyás AI (2015) Quantitative ultrastructural analysis of basket and axo-axonic cell terminals in the mouse hippocampus. Brain Struct Funct 220: 919-940. CrossRef Medline.
104. Tam J, Cinar R, Liu J, Godlewski G, Wesley D, Jourdan T, Szanda G, Mukhopadhyay B, Chedester L, Liow JS, Innis RB, Cheng K, Rice KC, Deschamps JR, Chorvat RJ, McElroy JF, Kunos G (2012) Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab 16: 167-179. CrossRef Medline.
105. Thibault K, Carrel D, Bonnard D, Gallatz K, Simon A, Biard M, Pezet S, Palkovits M, Lenkei Z (2013) Activation-dependent subcellular distribution patterns of CB1 cannabinoid receptors in the rat forebrain. Cereb Cortex 23: 2581-2591. CrossRef Medline.
106. Twitchell W, Brown S, Mackie K (1997) Cannabinoids inhibit N-and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78: 43-50. Medline.
107. Uchigashima M, Yamazaki M, Yamasaki M, Tanimura A, Sakimura K, Kano M, Watanabe M (2011) Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus. J Neurosci 31: 7700-7714. CrossRef Medline.
108. Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ (2010) Endocannabinoid signalling: has it got rhythm? Br J Pharmacol 160: 530-543. CrossRef Medline.
109. Vida I, Halasy K, Szinyei C, Somogyi P, Buhl EH (1998) Unitary IPSPs evoked by interneurons at the stratum radiatum-stratum lacunosummoleculare border in the CA1 area of the rat hippocampus in vitro. J Physiol 506: 755-773. CrossRef Medline.
110. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, Watanabe M (2006) Localization of diacylglycerol lipase-α around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 26: 4740-4751. CrossRef Medline.
111. You IJ, Jung YH, Kim MJ, Kwon SH, Hong SI, Lee SY, Jang CG (2012) Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-HT1A, GABA(A), and NMDA receptors. Neuropharmacology 62: 1034-1043. CrossRef Medline.
112. Zhu PJ, LovingerDM (2005) Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. J Neurosci 25: 6199-6207. CrossRef Medline.
113. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457. CrossRef Medline.
114. Zygmunt PM, Ermund A, Movahed P, Andersson DA, Simonsen C, Jönsson BA, Blomgren A, Birnir B, Bevan S, Eschalier A, Mallet C, Gomis A, Högestätt ED (2013) Monoacylglycerols activate TRPV1-a link between phospholipase C and TRPV1. PLoS One 8: e81618. CrossRef Medline.